FT Biotechnology 50 RE
Name
As of 08/31/2021Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
23.4%
1 yr return
N/A
3 Yr Avg Return
N/A
5 Yr Avg Return
N/A
Net Assets
$N/A
Holdings in Top 10
59.0%
52 WEEK LOW AND HIGH
$12.9
$9.18
$13.05
Expenses
OPERATING FEES
Expense Ratio 0.22%
SALES FEES
Front Load 0.00%
Deferred Load 2.25%
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
$500
Fund Classification
Fund Type
Unknown
Name
As of 08/31/2021Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
FOEHQX - Profile
Distributions
- YTD Total Return 23.4%
- 3 Yr Annualized Total Return 17.0%
- 5 Yr Annualized Total Return 15.1%
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 0.0%
- Dividend Distribution Frequency Semi-Annually
Fund Details
-
Legal NameBiotechnology Portfolio, Series 50
-
Fund Family NameFirst Trust Portfolios L.P.
-
Inception DateAug 24, 2020
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUnited States
Fund Description
FOEHQX - Performance
Return Ranking - Trailing
Period | FOEHQX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 23.4% | -25.6% | 23.4% | 0.56% |
1 Yr | N/A | -30.0% | 21.8% | N/A |
3 Yr | N/A* | -18.7% | 19.7% | N/A |
5 Yr | N/A* | -14.7% | 15.3% | N/A |
10 Yr | N/A* | -6.2% | 15.7% | N/A |
* Annualized
Return Ranking - Calendar
Period | FOEHQX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -53.9% | 11.7% | N/A |
2022 | N/A | -22.3% | 18.5% | N/A |
2021 | N/A | -4.7% | 41.4% | N/A |
2020 | N/A | -10.2% | 13.1% | N/A |
2019 | N/A | -5.7% | 26.9% | N/A |
Total Return Ranking - Trailing
Period | FOEHQX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 23.4% | -41.2% | 23.4% | 0.56% |
1 Yr | 18.3% | -30.0% | 28.3% | 3.95% |
3 Yr | 17.0%* | -18.7% | 19.7% | 1.84% |
5 Yr | 15.1%* | -14.7% | 15.3% | 2.13% |
10 Yr | N/A* | -6.2% | 15.7% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | FOEHQX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -53.9% | 11.7% | N/A |
2022 | N/A | -22.3% | 18.5% | N/A |
2021 | N/A | -4.7% | 41.4% | N/A |
2020 | N/A | -10.2% | 13.1% | N/A |
2019 | N/A | -5.7% | 26.9% | N/A |
NAV & Total Return History
FOEHQX - Holdings
Concentration Analysis
FOEHQX | Category Low | Category High | FOEHQX % Rank | |
---|---|---|---|---|
Net Assets | N/A | 732 K | 46.2 B | N/A |
Number of Holdings | 25 | 21 | 473 | 97.38% |
Net Assets in Top 10 | 5.9 M | 2.18 K | 21.6 B | 79.58% |
Weighting of Top 10 | 58.99% | 12.3% | 80.8% | 9.95% |
Top 10 Holdings
- Moderna Inc 17.42%
- Alexion Pharmaceuticals Inc 6.21%
- Bio-Techne Corp 6.01%
- Repligen Corp 5.25%
- IQVIA Holdings Inc 5.15%
- Syneos Health Inc Class A 4.90%
- Novavax Inc 4.26%
- Thermo Fisher Scientific Inc 4.17%
- AbbVie Inc 4.00%
- AstraZeneca PLC ADR 3.97%
Asset Allocation
Weighting | Return Low | Return High | FOEHQX % Rank | |
---|---|---|---|---|
Stocks | 100.00% | 85.37% | 106.13% | 6.81% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 12.57% |
Other | 0.00% | -22.99% | 3.38% | 26.18% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 12.04% |
Cash | 0.00% | -0.10% | 9.01% | 84.29% |
Bonds | 0.00% | 0.00% | 12.39% | 8.38% |
Stock Sector Breakdown
Weighting | Return Low | Return High | FOEHQX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 4.19% |
Utilities | 0.00% | 0.00% | 0.00% | 5.76% |
Technology | 0.00% | 0.00% | 22.69% | 13.09% |
Real Estate | 0.00% | 0.00% | 7.13% | 10.99% |
Industrials | 0.00% | 0.00% | 7.02% | 10.99% |
Financial Services | 0.00% | 0.00% | 1.85% | 28.80% |
Energy | 0.00% | 0.00% | 0.00% | 5.76% |
Communication Services | 0.00% | 0.00% | 9.11% | 9.42% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 16.75% |
Consumer Cyclical | 0.00% | 0.00% | 14.20% | 10.99% |
Basic Materials | 0.00% | 0.00% | 14.83% | 34.55% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | FOEHQX % Rank | |
---|---|---|---|---|
US | 88.90% | 53.67% | 104.41% | 39.79% |
Non US | 11.10% | 0.00% | 45.40% | 50.26% |
FOEHQX - Expenses
Operational Fees
FOEHQX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.22% | 0.08% | 3.13% | 95.36% |
Management Fee | N/A | 0.00% | 1.25% | N/A |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
FOEHQX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | 0.00% | 0.00% | 5.75% | 81.08% |
Deferred Load | 2.25% | 1.00% | 5.00% | 17.65% |
Trading Fees
FOEHQX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
FOEHQX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | N/A | 0.00% | 238.00% | N/A |
FOEHQX - Distributions
Dividend Yield Analysis
FOEHQX | Category Low | Category High | FOEHQX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 2.44% | 1.53% |
Dividend Distribution Analysis
FOEHQX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Semi-Annually | Annually | Quarterly | Annually |
Net Income Ratio Analysis
FOEHQX | Category Low | Category High | FOEHQX % Rank | |
---|---|---|---|---|
Net Income Ratio | N/A | -2.54% | 1.92% | N/A |
Capital Gain Distribution Analysis
FOEHQX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually |